Related Experiment Video
Updated: Mar 15, 2026

14:49
Clinical Protocol of Producing Adipose Tissue-Derived Stromal Vascular Fraction for Potential Cartilage Regeneration
Published on: September 29, 2018
42.6K
Adipose-derived stem cells in cartilage regeneration: current perspectives
Alessandra Bielli1, Maria Giovanna Scioli1, Pietro Gentile2
1Anatomic Pathology, Department of Biomedicine & Prevention, Tor Vergata University of Rome, Italy.
Regenerative Medicine
|September 7, 2016
Summary
Human adipose-derived stem cells (ASCs) show promise for cartilage repair due to their differentiation potential. Further research is needed to translate these regenerative strategies into clinical practice for musculoskeletal medicine.
Area of Science:
- Musculoskeletal Medicine
- Regenerative Medicine
- Biomaterials Science
Background:
- Adult cartilage has limited self-renewal capacity, posing challenges for injury repair.
- Traditional chondrocyte-based therapies are hindered by low cell proliferation rates.
- Regenerative strategies combining cells, scaffolds, and growth factors are under investigation.
Purpose of the Study:
- To explore human adipose-derived stem cells (ASCs) as an alternative for chondrogenesis.
- To investigate the chondrogenic potential of ASCs in collagen gel scaffolds.
- To understand the biomolecular mechanisms and regenerative properties of ASCs in bioengineered scaffolds.
Main Methods:
- Utilizing human adipose-derived stem cells (ASCs) for chondrogenesis.
- Entrapping ASCs within collagen gel scaffolds.
- Investigating ASC differentiation and regenerative properties in vitro and in bioengineered scaffolds.
Main Results:
- ASCs demonstrated spontaneous chondrogenic differentiation when entrapped in collagen gel scaffolds.
- Biomolecular mechanisms underlying ASC chondrogenesis in vitro were identified.
- Preclinical data suggest regenerative potential for ASCs in engineered scaffolds with growth factors.
Conclusions:
- ASCs offer a promising cell source for cartilage regeneration, overcoming limitations of chondrocytes.
- Bioengineered ASC-based strategies show potential for treating cartilage defects.
- Further clinical validation is required to translate these preclinical findings into effective patient treatments.

